Mahmut Nedim Aban
- 4.8 Excellent • 169 avis
- 41 années d'expérience
- Turquie, Istanbul, Lokman Hekim Istanbul Hospital
Le Dr Ozadli est spécialisé dans le cancer de la thyroïde et possède une vaste formation à l'hôpital d'oncologie d'Ankara, l'un des principaux centres de cancérologie de Turquie.
Spécialisé dans le cancer de la thyroïde et d'autres pathologies oncologiques, formé dans des centres internationaux prestigieux tels que le MD Anderson Cancer Center et le Sunnybrook Odette Cancer Center.
Plus de 900 interventions réalisées – Le Dr Yildiz se spécialise en oncologie mammaire à l'hôpital universitaire Medipol Mega.
Le professeur associé Tahsin Ozatli apporte son expertise spécialisée en oncologie à l'hôpital universitaire Istinye Liv, en se concentrant sur les cancers du sein, du poumon et gastro-intestinaux.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Spécialisé en oncologie médicale à l'université de Kocaeli – axé sur les traitements personnalisés contre le cancer.
Le Pr Gul Alco est spécialisé en radio-oncologie pour le cancer de la thyroïde à l'Université Medipol d'Istanbul, apportant des décennies d'expérience dédiée.
Spécialisé en chirurgie laparoscopique avancée et oncologique – Muzaffer Al a suivi une formation approfondie dans des institutions médicales de premier plan.
Le professeur associé Nail Paksoy est spécialisé dans le traitement du cancer de la thyroïde à l'hôpital Medipol Bahçelievler, avec une certification de l'ESMO en oncologie médicale.
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Le Dr Karatas a été formé dans des institutions internationales de premier plan, notamment l'Université d'État de l'Ohio et la faculté de médecine de Hanovre, avec une spécialisation en chirurgie de la tête et du cou.
Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).
She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).
Spécialiste de la chirurgie du cancer de la thyroïde aux hôpitaux Büyük Anadolu, avec une expertise dans plusieurs domaines de l'oncologie chirurgicale.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Le Dr Sahibov est spécialisé dans le traitement du cancer de la thyroïde, formé au département d'oncologie radiothérapique de l'université de Marmara.
Le Dr Topcu a été formé dans les plus grands centres de cancérologie, tels que MD Anderson et Sunnybrook, se concentrant sur le cancer de la thyroïde ainsi que sur d'autres pathologies malignes.